Novo Nordisk (NVO) reported Q1 earnings on May 2. Even though it was a positive report, sales of its weight-loss drug Wegovy came in below expectations, causing the NVO stock price to fall lower. The selloff may have been an initial and short-lived reaction, as NVO pivoted and gapped up…
In this edition of StockCharts TV‘s The Final Bar, Dave focuses in on price pattern analysis for the S&P 500, then…
In this edition of StockCharts TV‘s The Final Bar, Dave recaps another strong day for stocks as the S&P 500 regains…
EB Weekly Market Recap Video If you haven’t seen our latest weekend recording, it’s now available HERE at YouTube.com.…
Today Erin uncovers two industry groups that are showing strength and potential in the short term. She takes a…
Good morning and welcome to this week’s Flight Path. The equity “NoGo” trend struggled this week as prices climbed from…
We’ve all heard that popular Wall Street adage, “Go away in May”, right? It’s cute and it rhymes, so…
Stocks fell sharply into late April and then rebounded over the last two weeks. SPY fell 5.34% from March…
The weaker-than-expected jobs report gave the stock market some direction, a nice treat before the 150th Kentucky Derby. Job…